Showing results (611-620 of 636) with videos related to

Sort By:
Pageof 64
European Journal of Heart Failure|September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trialAnkeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.
European Heart Journal|August 27, 2022
Dapagliflozin for heart failure according to body mass index: the DELIVER trialCarly Adamson, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the AmericasPooja Dewan, Pardeep S Jhund, Li Shen, et al.
Circulation|October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HFPardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
JACC. Heart Failure|March 7, 2023
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction SpectrumJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
Circulation|November 7, 2022
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVERXiaowen Wang, Muthiah Vaduganathan, Brian L Claggett, et al.
Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence|January 26, 2026
MedAlign: A Clinician-Generated Dataset for Instruction Following with Electronic Medical RecordsScott L Fleming, Alejandro Lozano, William J Haberkorn, et al.
Circulation|August 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Pageof 64